Compare Acadia Healthcare Company Inc (ACHC) vs Aterian Inc (ATER) Price & Performance

ACHC trades at $31.53, up 2.64% today, with a neutral technical signal despite bullish moving averages. The company shows strong revenue growth with Q2 2026 earnings beating estimates, but faces profitability challenges with negative net income margins. Analyst consensus remains positive with 68% buy ratings and a $36 price target, though ongoing legal investigations create headwinds.

The outlook balances operational strength against financial risks. Revenue growth and facility expansion support upside potential, but negative profitability and legal uncertainties warrant caution. The stock offers 14% upside to consensus target if execution improves, but investors should monitor earnings sustainability and legal developments closely.

Aterian (ATER) trades at $0.4934, up 7.03% in the last 24 hours, with a bearish technical signal overall. The company reported revenue of $68.98 million in 2025 but a net loss of $18.98 million, showing negative margins despite recent earnings beats. Recent news highlights a pending asset sale vote that could return $0.85–$1.14 per share to stockholders, creating near-term event-driven volatility.

The outlook hinges on the asset sale outcome, offering potential shareholder returns but also signaling business contraction. Risks include persistent cash burn, declining revenue, and high negative equity. Analysts are split 50/50 buy/hold, reflecting uncertainty amid restructuring efforts.